AU2022270639A1 - Solid forms of (r)-oxybutynin d-malate - Google Patents

Solid forms of (r)-oxybutynin d-malate Download PDF

Info

Publication number
AU2022270639A1
AU2022270639A1 AU2022270639A AU2022270639A AU2022270639A1 AU 2022270639 A1 AU2022270639 A1 AU 2022270639A1 AU 2022270639 A AU2022270639 A AU 2022270639A AU 2022270639 A AU2022270639 A AU 2022270639A AU 2022270639 A1 AU2022270639 A1 AU 2022270639A1
Authority
AU
Australia
Prior art keywords
oxybutynin
crystalline
malate
salt
malate salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022270639A
Other languages
English (en)
Inventor
Sean Johnston
Dennis MOLNAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apnimed Inc
Original Assignee
Apnimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2021/030571 external-priority patent/WO2021226020A1/en
Application filed by Apnimed Inc filed Critical Apnimed Inc
Publication of AU2022270639A1 publication Critical patent/AU2022270639A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/255—Tartaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2022270639A 2021-05-04 2022-05-04 Solid forms of (r)-oxybutynin d-malate Pending AU2022270639A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AUPCT/US2021/030571 2021-05-04
PCT/US2021/030571 WO2021226020A1 (en) 2020-05-05 2021-05-04 Polymorphic forms of (r)-oxybutynin hydrochloride
US202163248684P 2021-09-27 2021-09-27
US63/248,684 2021-09-27
PCT/US2022/027573 WO2022235726A1 (en) 2021-05-04 2022-05-04 Solid forms of (r)-oxybutynin d-malate

Publications (1)

Publication Number Publication Date
AU2022270639A1 true AU2022270639A1 (en) 2023-12-14

Family

ID=81654984

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022270639A Pending AU2022270639A1 (en) 2021-05-04 2022-05-04 Solid forms of (r)-oxybutynin d-malate

Country Status (7)

Country Link
US (1) US20240217918A1 (https=)
EP (1) EP4334281A1 (https=)
JP (1) JP2024518370A (https=)
KR (1) KR20240004600A (https=)
AU (1) AU2022270639A1 (https=)
CA (1) CA3215373A1 (https=)
WO (1) WO2022235726A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
WO2009122429A2 (en) * 2008-02-04 2009-10-08 Matrix Laboratories Limited Crystalline oxybutynin and process for preparing the same
CN104370760B (zh) * 2013-11-29 2016-06-01 江苏汉邦科技有限公司 模拟移动床色谱拆分奥昔布宁对映体的方法
KR102874891B1 (ko) 2018-01-30 2025-10-21 애프니메드, 인코포레이티드 (델라웨어) 수면 무호흡증을 치료하기 위한 방법 및 조성물

Also Published As

Publication number Publication date
CA3215373A1 (en) 2022-11-10
JP2024518370A (ja) 2024-05-01
US20240217918A1 (en) 2024-07-04
KR20240004600A (ko) 2024-01-11
EP4334281A1 (en) 2024-03-13
WO2022235726A1 (en) 2022-11-10

Similar Documents

Publication Publication Date Title
AU2014239995B2 (en) Salt of omecamtiv mecarbil and process for preparing salt
JP7734700B2 (ja) ベータアドレナリンアゴニストの形態及び組成物
AU2007284851B2 (en) Crystalline antifungal compounds
US20240217944A1 (en) Salt forms of r-mdma and methods using the same
US10683326B2 (en) Crystalline salt forms
CN104159584A (zh) 阿瑞吡坦l-脯氨酸溶剂化物-组合物和共晶体
JP5336509B2 (ja) （ｒ）−３−フルオロフェニル−３，４，５−トリフルオロベンジルカルバミン酸１−アザビシクロ［２．２．２］オクト−３−イルエステルの安定な結晶性塩
US7432398B2 (en) Inorganic acid salts of sibutramine
US20240217918A1 (en) Solid forms of (r)-oxybutynin d-malate
US7393977B2 (en) Dicarboxylic acid salt of sibutramine
US7429679B2 (en) Sulphonic acid salt of sibutramine
EP1451166B1 (en) Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
CN117396460A (zh) (r)-奥昔布宁d-苹果酸盐的固体形式
WO2021226020A1 (en) Polymorphic forms of (r)-oxybutynin hydrochloride
US20260022091A1 (en) Polymorphic forms of (r)-oxybutynin hydrochloride
EA051728B1 (ru) Полиморфные формы (r)-оксибутинина гидрохлорида
MX2011002728A (es) Nueva sal de derivado de morfolina.